141 related articles for article (PubMed ID: 34690297)
1. The Effectiveness of Methylprednisolone as a Premedication Among the Pediatric Population for Preventing Infusion-Related Reactions to Infliximab.
Zeng-Wang YM; Cares K; Thomas R; El-Baba M
Gastroenterol Nurs; 2021 Nov-Dec 01; 44(6):449-454. PubMed ID: 34690297
[TBL] [Abstract][Full Text] [Related]
2. Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study.
Gold SL; Cohen-Mekelburg S; Schneider Y; Shen N; Faggen A; Rupert A; Scherl EJ; Bosworth B; Steinlauf A
Inflamm Bowel Dis; 2017 Oct; 23(10):1882-1889. PubMed ID: 28837521
[TBL] [Abstract][Full Text] [Related]
3. Premedication prevents infusion reactions and improves retention rate during infliximab treatment.
Bartoli F; Bruni C; Cometi L; Blagojevic J; Fiori G; Tofani L; Galluccio F; Furst DE; Matucci Cerinic M
Clin Rheumatol; 2016 Nov; 35(11):2841-2845. PubMed ID: 27436188
[TBL] [Abstract][Full Text] [Related]
4. [PREMEDICATION WITH CORTICOSTEROIDS PRIOR TO IV INFLIXIMAB - A COMPARISON BETWEEN INFLAMMATORY BOWEL DISEASE (IBD) AND RHEUMATIC PATIENTS].
Oshri D; Schwarz D; Vodonos A; Zimhony N; Abu-Shakra M; Zeller L
Harefuah; 2019 Sep; 158(9):571-575. PubMed ID: 31507106
[TBL] [Abstract][Full Text] [Related]
5. Infliximab in inflammatory bowel disease. Is premedication necessary?
Nuñez F P; Quera R; Simian D; Flores L; Figueroa C; Ibañez P; Kronberg U; Lubascher J; Pizarro G
Gastroenterol Hepatol; 2021 May; 44(5):321-329. PubMed ID: 33386199
[TBL] [Abstract][Full Text] [Related]
6. Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium.
Jacobstein DA; Markowitz JE; Kirschner BS; Ferry G; Cohen SA; Gold BD; Winter HS; Heyman MB; Baldassano RN
Inflamm Bowel Dis; 2005 May; 11(5):442-6. PubMed ID: 15867583
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Rapid vs Standard Infliximab Infusions in the Pediatric Population.
Rozette NA; Hellauer CM; McKee C; Vazifedan T; Gabriel CA; Dice JE; Yokois NU
Inflamm Bowel Dis; 2018 Aug; 24(9):2007-2014. PubMed ID: 29788416
[TBL] [Abstract][Full Text] [Related]
8. Premedication with intravenous steroids does not influence the incidence of infusion reactions following infliximab infusions in pediatric inflammatory bowel disease patients-a case-control study.
van Wassenaer EA; Meester VL; Kindermann A; Koot BGP; Benninga MA; de Meij TGJ
Eur J Clin Pharmacol; 2019 Oct; 75(10):1445-1450. PubMed ID: 31332475
[TBL] [Abstract][Full Text] [Related]
9. Prevention of acute adverse events related to infliximab infusions in pediatric patients.
Lahdenne P; Wikström AM; Aalto K; Kolho KL
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):785-90. PubMed ID: 20535789
[TBL] [Abstract][Full Text] [Related]
10. Premedication as primary prophylaxis does not influence the risk of acute infliximab infusion reactions in immune-mediated inflammatory diseases: A systematic review and meta-analysis.
Fumery M; Tilmant M; Yzet C; Brazier F; Loreau J; Turpin J; Le Mouel JP; Goeb V; Nguyen-Khac E; Singh S; Dupas JL; Diouf M
Dig Liver Dis; 2019 Apr; 51(4):484-488. PubMed ID: 30686715
[TBL] [Abstract][Full Text] [Related]
11. Rapid infusion of infliximab biosimilars and the incidence and severity of infusion-related reactions in patients with inflammatory bowel disease.
Rusch C; Wood M; Kennedy AG; Tompkins BJ; Frasca JD
J Clin Pharm Ther; 2022 Nov; 47(11):1851-1857. PubMed ID: 36134561
[TBL] [Abstract][Full Text] [Related]
12. A one-hour infusion of infliximab during maintenance therapy is safe and well tolerated: a prospective cohort study.
Lee TW; Singh R; Fedorak RN
Aliment Pharmacol Ther; 2011 Jul; 34(2):181-7. PubMed ID: 21615434
[TBL] [Abstract][Full Text] [Related]
13. Rapid Infliximab Infusion in Children: A Multicenter Retrospective Cohort Study.
Lev-Tzion R; Assa A; Yerushalmi B; Lahad A; Friedman M; Ledder O; Turner D
J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):e101-e103. PubMed ID: 29064928
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting.
Checkley LA; Kristofek L; Kile S; Bolgar W
Dig Dis Sci; 2019 Mar; 64(3):855-862. PubMed ID: 30311152
[TBL] [Abstract][Full Text] [Related]
15. Safety of Rapid Infliximab Biosimilar Infusions in Patients With Inflammatory Bowel Disease.
Kim JY; Bhat S
Ann Pharmacother; 2022 Mar; 56(3):280-284. PubMed ID: 34192881
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab].
Bermejo F; López San Román A; Algaba A; van Domselaar M; Carneros JA; Rivero M; Piqueras B; Valer MP
Gastroenterol Hepatol; 2008 Dec; 31(10):629-32. PubMed ID: 19174078
[TBL] [Abstract][Full Text] [Related]
17. Incidence and Management of Infusion Reactions to Infliximab in a Prospective Real-world Community Registry.
Choquette D; Faraawi R; Chow A; Rodrigues J; Bensen WJ; Nantel F
J Rheumatol; 2015 Jul; 42(7):1105-11. PubMed ID: 26077415
[TBL] [Abstract][Full Text] [Related]
18. Safety of Rapid Infliximab Infusions in Children: A Systematic Review.
van Wassenaer EA; van Oosterhout JPM; Daams JG; van den Berg MJM; van der Lee H; D'Haens GR; de Meij TGJ; Benninga MA; Koot BGP
J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):361-365. PubMed ID: 32558671
[TBL] [Abstract][Full Text] [Related]
19. A nurse-led accelerated procedure for infliximab infusion is well tolerated and effective in patients with inflammatory bowel disease.
Michielan A; Martinato M; Favarin A; Zanotto V; Caccaro R; Caruso A; Sturniolo GC; D'Incà R
Dig Liver Dis; 2015 May; 47(5):372-7. PubMed ID: 25708258
[TBL] [Abstract][Full Text] [Related]
20. Safety of Hydrocortisone Premedication Discontinuation in Patients with Inflammatory Bowel Disease on Maintenance Therapy with Infliximab: a Prospective Clinical and Pharmacological Study.
Tran-Minh ML; Gornet JM; Maillet M; Houze P; Simon M; McLellan P; Hassid D; Vivier-Chicoteau J; Baudry C; Hammoudi N; Allez M
J Crohns Colitis; 2021 May; 15(5):742-748. PubMed ID: 33205193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
